Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Relay Therapeutics (RLAY) Intangibles (2021 - 2025)

Relay Therapeutics (RLAY) has disclosed Intangibles for 5 consecutive years, with $2.3 million as the latest value for Q1 2025.

  • Quarterly Intangibles changed 0.0% to $2.3 million in Q1 2025 from the year-ago period, while the trailing twelve-month figure was $2.3 million through Mar 2025, changed 0.0% year-over-year, with the annual reading at $2.3 million for FY2024, 0.0% changed from the prior year.
  • Intangibles for Q1 2025 was $2.3 million at Relay Therapeutics, roughly flat from $2.3 million in the prior quarter.
  • The five-year high for Intangibles was $2.3 million in Q2 2021, with the low at $2.3 million in Q2 2021.
  • Average Intangibles over 5 years is $2.3 million, with a median of $2.3 million recorded in 2021.
  • Peak annual rise in Intangibles hit 0.0% in 2022, while the deepest fall reached 0.0% in 2022.
  • Over 5 years, Intangibles stood at $2.3 million in 2021, then changed by 0.0% to $2.3 million in 2022, then changed by 0.0% to $2.3 million in 2023, then changed by 0.0% to $2.3 million in 2024, then changed by 0.0% to $2.3 million in 2025.
  • According to Business Quant data, Intangibles over the past three periods came in at $2.3 million, $2.3 million, and $2.3 million for Q1 2025, Q4 2024, and Q3 2024 respectively.